RTP801 is a critical factor in the neurodegeneration process of A53T α‐synuclein in a mouse model of Parkinson's disease under chronic restraint stress

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|175|4|590-605

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.175, Iss.4, 2018-02, pp. : 590-605

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A new role for α‐synuclein in Parkinson's disease: Alteration of ER–mitochondrial communication

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 8, 2015-07 ,pp. : 1026-1033

John Wiley & Sons Inc

Access to resources Recommend Favorite

Parkinson's disease correlates with promoter methylation in the α‐synuclein gene

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 4, 2015-04 ,pp. : 577-580

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vivo gastric detection of α‐synuclein inclusions in Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 4, 2015-04 ,pp. : 517-524

John Wiley & Sons Inc

Access to resources Recommend Favorite

Head injury, α‐synuclein genetic variability and Parkinson's disease

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 874-878

John Wiley & Sons Inc

Access to resources Recommend Favorite

L‐dopa increases α‐synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 13, 2015-11 ,pp. : 1794-1801

John Wiley & Sons Inc

Access to resources Recommend Favorite